Attached files
| file | filename |
|---|---|
| EX-3.1 - ARTICLES OF INCORPORATION OF THE REGISTRANT - PROTO SCRIPT PHARMACEUTICAL CORP | exhibit3.htm |
| EX-3.2 - BYLAWS OF THE REGISTRANT - PROTO SCRIPT PHARMACEUTICAL CORP | bylawsyanex.htm |
| EX-23.1 - CONSENT OF SILBERSTEIN UNGAR, PLLC - PROTO SCRIPT PHARMACEUTICAL CORP | consents1yanex053111062411.htm |
| EX-10.1 - PROFESSIONAL SERVICE AGREEMENT WITH EBBY KURIAKOSE MOOLAYIL DATED MAY 19, 2011 - PROTO SCRIPT PHARMACEUTICAL CORP | professionalservicesagreemen.htm |
| S-1 - FORM S-1 - PROTO SCRIPT PHARMACEUTICAL CORP | s1yanexjune24.htm |
Exhibit 5.1
Stepp Law Corporation
15707 Rockfield Blvd.
Suite 101
Irvine, California 92618
949.660.9700
June 13, 2011
Yanex Group, Inc.
Filderbahnplatz, 33-1404
Stuttgart, Germany 70567
Attention: Alexander Yanov
Re: Registration Statement on Form S-1
Dear Mr. Yanov:
As special counsel to Yanex Group, Inc., a Nevada corporation (the "Company"), we have been requested to provide our opinion regarding 1,500,000 shares of the Company’s $.001 par value common stock to be registered for sale by the Company pursuant to the provisions of that certain registration statement on Form S-1, which is anticipated to be filed by the Company with the Securities and Exchange Commission (the "Registration Statement") (the “Shares”). Accordingly, the purpose of this letter is to respond, in writing, to that request and furnish that opinion. The opinion specified in this letter is limited to Nevada law.
It is our opinion that the Shares (i) have been duly and validly authorized for issuance and (ii) when issued pursuant to the Registration Statement, will be validly issued, fully paid, and non-assessable.
We confirm that we furnish no opinion with respect to the truth and accuracy or the completeness of the Registration Statement. The opinion specified in this letter is expressly limited to the matters specified in this letter, and we furnish no opinion, express or implied, as to any other matter relating to the Company or its securities. Accordingly, no provision of this letter is intended to, nor shall any such provision, be construed as an opinion concerning any matter not specified in this letter.
We consent to the (i) use of this letter as an exhibit to the Registration Statement, (ii) disclosure in the prospectus portion of the Registration Statement of the opinion specified in this letter, and (iii) use of our name in the Registration Statement. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required pursuant to Section 7 of the Securities Act of 1933, or the rules and regulations of the Securities and Exchange Commission.
The Company is hereby advised, urged, and encouraged to consult with and, if appropriate, retain securities counsel in each jurisdiction outside the United States in which the Shares may be offered and sold regarding compliance with the securities laws of such jurisdiction.
Finally, of course, in the event that you have questions or comments regarding this matter, please do not hesitate to contact us. Thank you.
Sincerely,
STEPP LAW CORPORATION
/s/ Thomas E. Stepp
By: Thomas E. Stepp, Jr.
TES/jkl